Karo Healthcare Welcomes Konstanze Gallinatus as Chief Transformation Officer
Karo Healthcare has taken a significant step forward in its pursuit of aggressive growth by appointing Konstanze Gallinatus as its Chief Transformation Officer. This strategic decision was announced on September 30, 2025, as part of the company's vision to evolve into one of Europe’s leading consumer healthcare firms, targeting revenues exceeding EUR 1 billion by 2030. Karo aims for industry-leading profitability, and the addition of Gallinatus to the corporate management team will play a crucial role in realizing this ambition.
Konstanze's extensive background in transformation initiatives, pricing strategies, and demand management will bolster Karo's leadership as the company ventures deeper into its growth strategy. "We are delighted to welcome Konstanze to Karo," said Christoffer Lorenzen, CEO of Karo Healthcare. He emphasized her remarkable leadership qualities and experience in executing transformative strategies within a private equity framework, which are vital for Karo’s upcoming growth journey alongside its new owner, KKR.
Her appointment comes ahead of what Karo sees as a pivotal integration of the Perrigo Skin Health business, pending regulatory approvals. This integration is anticipated to enhance Karo’s product offerings and market position significantly.
Before joining Karo, Gallinatus served at Douglas Group AG, a premier European omnichannel retailer in the beauty sector. There, she was instrumental in driving strategy and transformation, particularly in her capacities as Executive Vice President for Program Management and Chief Pricing and Demand Officer. She is credited with generating over €100 million in EBITDA improvement through the implementation of a robust value creation plan. In addition, she established centralized teams focused on pricing and demand forecasting, enhancing operational efficiencies across the company.
Her professional journey also includes experience with OCC Strategy Consultants and leadership roles in various startups, showcasing her adaptability and leadership skills. As she transitions to Karo, her excitement about joining the organization reflects a mutual commitment to growth and innovation. "I am very excited to join Karo at this important point in its development," Gallinatus stated. She looks forward to leveraging her experience to contribute to Karo's ongoing transformation and growth.
Karo Healthcare, recognized for its commitment to providing 'smart choices for everyday healthcare', operates in more than 90 countries and is known for a portfolio of trustworthy brands including Lamisil, E45, and Proct. The company, headquartered in Stockholm, employs approximately 470 individuals across 13 international hubs, exemplifying its expansive footprint in the consumer healthcare market.
This strategic appointment not only reinforces Karo’s leadership team but also sets a strong foundation for future endeavors aimed at ensuring the company's sustained growth and market competitiveness. The healthcare sector is evolving rapidly, and Karo’s proactive approach in enhancing its management structure underscores its ambition to achieve greater heights in the industry. As Karo embarks on this transformative journey, the integration of innovative practices and strategies will be pivotal in achieving its goals and realizing its long-term value creation plans. The leadership team, led by Gallinatus, is expected to navigate Karo through the changing landscape of consumer healthcare, unlocking new avenues for growth and success in the near future.
Konstanze's extensive background in transformation initiatives, pricing strategies, and demand management will bolster Karo's leadership as the company ventures deeper into its growth strategy. "We are delighted to welcome Konstanze to Karo," said Christoffer Lorenzen, CEO of Karo Healthcare. He emphasized her remarkable leadership qualities and experience in executing transformative strategies within a private equity framework, which are vital for Karo’s upcoming growth journey alongside its new owner, KKR.
Her appointment comes ahead of what Karo sees as a pivotal integration of the Perrigo Skin Health business, pending regulatory approvals. This integration is anticipated to enhance Karo’s product offerings and market position significantly.
Before joining Karo, Gallinatus served at Douglas Group AG, a premier European omnichannel retailer in the beauty sector. There, she was instrumental in driving strategy and transformation, particularly in her capacities as Executive Vice President for Program Management and Chief Pricing and Demand Officer. She is credited with generating over €100 million in EBITDA improvement through the implementation of a robust value creation plan. In addition, she established centralized teams focused on pricing and demand forecasting, enhancing operational efficiencies across the company.
Her professional journey also includes experience with OCC Strategy Consultants and leadership roles in various startups, showcasing her adaptability and leadership skills. As she transitions to Karo, her excitement about joining the organization reflects a mutual commitment to growth and innovation. "I am very excited to join Karo at this important point in its development," Gallinatus stated. She looks forward to leveraging her experience to contribute to Karo's ongoing transformation and growth.
Karo Healthcare, recognized for its commitment to providing 'smart choices for everyday healthcare', operates in more than 90 countries and is known for a portfolio of trustworthy brands including Lamisil, E45, and Proct. The company, headquartered in Stockholm, employs approximately 470 individuals across 13 international hubs, exemplifying its expansive footprint in the consumer healthcare market.
This strategic appointment not only reinforces Karo’s leadership team but also sets a strong foundation for future endeavors aimed at ensuring the company's sustained growth and market competitiveness. The healthcare sector is evolving rapidly, and Karo’s proactive approach in enhancing its management structure underscores its ambition to achieve greater heights in the industry. As Karo embarks on this transformative journey, the integration of innovative practices and strategies will be pivotal in achieving its goals and realizing its long-term value creation plans. The leadership team, led by Gallinatus, is expected to navigate Karo through the changing landscape of consumer healthcare, unlocking new avenues for growth and success in the near future.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.